Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk.

Abstract

In its successful annual cycle of controversies and debates, the International Society of Prenatal Diagnosis and Therapy once again addressed non-invasive prenatal testing (NIPT) by following up on the 2013 controversy, 'Should non-invasive DNA testing be the standard screening test for Down syndrome in all pregnant women'? with the proposition, 'NIPT for chromosomel abnormalities should be offered to women with low a priori risk'.

• Authors: Jan M M Van Lith, Brigitte H W Faas, Diana W Bianchi
• Journal: Prenatal diagnosis (Prenat Diagn) Vol. 35 Issue 1 Pg. 8-14 (Jan 2015) ISSN: 1097-0223 [Electronic] England
• PMID: 25393690 (Publication Type: Journal Article)
• Copyright: © 2014 John Wiley & Sons, Ltd.

Topics

• Chromosome Disorders (blood, diagnosis, etiology)
• Down Syndrome (blood, diagnosis)
• Female
• Humans
• Infant, Newborn
• Pregnancy
• Prenatal Diagnosis (methods)
• Risk Factors